The Spatial Biology Company

Accelerate your biomarker vision

from discovery to translation

CODEX system

The CODEX® Solution

Ultrahigh multiplex imaging at single cell resolution

A simple benchtop solution for whole tissue imaging of 40+ protein markers and deep cellular phenotyping.

Vectra Polaris

The Phenoptics™ Solution

High throughput multiplex imaging with rapid whole slide scanning

A comprehensive solution for analyzing up to 8 protein markers and 80 slides per day. Includes the Vectra®  Polaris™ Instrument, Opal™ Panels, and inForm® Software.

Multi-Institutional Study of Immuno-Oncology Biomarkers

A seminal new study finds that spatial biomarkers outperform PD-L1 immunohistochemistry (IHC) and tumor mutational burden (TMB) in predicting response to checkpoint inhibitors.

Multi-Institutional Study of Immuno-Oncology Biomarkers

A seminal new study finds that spatial biomarkers outperform PD-L1 immunohistochemistry (IHC) and tumor mutational burden (TMB) in predicting response to checkpoint inhibitors.

Our Solutions

Multiplex-Image-Example-on-

Find out why studying tissue biomarkers and cell phenotypes within their spatial context is critical to understanding disease pathology and progression.

Explore how our multiplex imaging solutions can meet your needs for biomarker discovery and high throughput translational studies.

As pioneers in the field of multiplex spatial biology, our contract services team has several decades of multiplex IF/IHC experience to meet your outsourcing needs.

New Products

Our newest digital pathology solution for the storage, management and analysis of multiplex immunofluorescence digital slides.

These kits are part of the only validated end-to-end solution for quantitative multispectral data, crucial for melanoma samples in translational immuno-oncology research.

These complete staining kits include the 6 most clinically relevant, ready-to-use primary antibodies and their Opal™ fluorophores for lung cancer tissue.

OUR HISTORY represents the rapid advancement driving the field of multiplexed imaging and spatial biomarker analysis.

News

July 29,  2020

Akoya Biosciences Collaborates with Leading Cancer Center to Discover Predictive Biomarkers for Cancer

July 29, 2020
December 5, 2019

Akoya Biosciences Raises $50 Million in New Financing

December 5, 2019
November 8, 2019

Akoya Expands Spatial Biology Portfolio with Optimized PD-1/PD-L1 Panels for Melanoma and Lung Cancer

November 8, 2019

Virtual Events

Apr 24-29 | Booth #1031

Immuno-Oncology Virtual Tradeshow

Jun 3, 2020